N-[4-(2-Hydroxy-3-isopropylamino-propoxy)-5,6,7,8,9,9a-hexahydro-4bH-benzo[3,4]cyclobuta[1,2]cyclohepten-1-yl]-butyramide

ID: ALA165043

PubChem CID: 44378947

Max Phase: Preclinical

Molecular Formula: C23H36N2O3

Molecular Weight: 388.55

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CCCC(=O)Nc1ccc(OCC(O)CNC(C)C)c2c1[C@H]1CCCCC[C@@H]21

Standard InChI:  InChI=1S/C23H36N2O3/c1-4-8-21(27)25-19-11-12-20(28-14-16(26)13-24-15(2)3)23-18-10-7-5-6-9-17(18)22(19)23/h11-12,15-18,24,26H,4-10,13-14H2,1-3H3,(H,25,27)/t16?,17-,18+/m0/s1

Standard InChI Key:  YLBWVHADZBYSLQ-UQJFVLDMSA-N

Molfile:  

     RDKit          2D

 30 32  0  0  1  0  0  0  0  0999 V2000
    2.1750   -0.5125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1750    0.0958    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7792   -0.5125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7792    0.0875    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6542   -0.8125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6542   -1.4125    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.6542    0.3958    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1750   -1.7125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1375   -0.5125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6542    0.9958    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.7042   -1.6250    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.1375    0.0875    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4208    1.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.6167    0.9958    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1375    1.2958    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1000    1.3000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2042    0.5125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2042   -0.9292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6125    0.3958    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9458    1.3083    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1750   -2.3125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6542   -2.6125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4625    1.0083    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9375    1.9083    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7792    0.3625    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7292   -0.8917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6500   -3.2125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0542   -0.2792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7750   -1.1125    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
    2.7750    0.6958    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  1  1  0
  4  3  1  0
  5  1  2  0
  6  5  1  0
  7  2  2  0
  8  6  1  0
  9  5  1  0
 10  7  1  0
 11  8  2  0
 12  9  2  0
 13 16  1  0
 14 15  1  0
 15 10  1  0
 16 14  1  0
 17  4  1  0
 18  3  1  0
 19 14  1  0
 20 13  1  0
 21  8  1  0
 22 21  1  0
 23 20  1  0
 24 20  1  0
 25 17  1  0
 26 18  1  0
 27 22  1  0
 28 26  1  0
  3 29  1  1
  4 30  1  1
  4  2  1  0
  7 12  1  0
 25 28  1  0
M  END

Associated Targets(Human)

ADRB1 Tclin Adrenergic receptor beta; ADRB1 & ADRB2 (240 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Cavia porcellus (23802 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 388.55Molecular Weight (Monoisotopic): 388.2726AlogP: 4.31#Rotatable Bonds: 9
Polar Surface Area: 70.59Molecular Species: BASEHBA: 4HBD: 3
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: 14.00CX Basic pKa: 9.67CX LogP: 3.98CX LogD: 1.76
Aromatic Rings: 1Heavy Atoms: 28QED Weighted: 0.59Np Likeness Score: -0.39

References

1. Carre MC, Youlassani A, Caubere P, Saint-Aubin-Floch A, Blanc M, Advenier C..  (1984)  Synthesis of a novel series of (aryloxy)propanolamines: new selective beta 2-blocking agents.,  27  (6): [PMID:6145801] [10.1021/jm00372a016]

Source